Research published in Blood Advances in March 2026 establishes clear evidence linking Agent Orange exposure during the Vietnam War to myelodysplastic syndrome (MDS), a blood cancer that develops earlier and more aggressively in exposed individuals. The eight-year study through the MDS Natural History Study enrolled patients from 160 U.S. sites and found that 54% of Agent Orange-exposed participants developed MDS or precursor conditions versus 37% of unexposed participants, with exposed individuals showing more complex genetic mutations and disease progression. Despite the findings, the Department of Veterans Affairs does not recognize MDS as presumptively linked to Agent Orange as of March 2026, forcing veterans to individually prove service connection for benefits. Black veterans face three times higher likelihood of Agent Orange exposure compared to white veterans, suggesting disproportionate health impacts. Lead researcher Mikkael Sekeres hopes the study will enable aging veterans to access disability compensation and treatment as MDS progresses to life-threatening stages requiring transfusions.
Story comments
Loading comments…